Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
Report ID | 108975 |
Drug Identification Number | 02220296 |
Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
Common or Proper name | Penicillin |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | PENICILLIN G |
Strength(s) | 10000000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 50 ml |
ATC code | J01CE |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-03-16 |
Actual start date | 2020-03-16 |
Estimated end date | Unknown |
Actual end date | 2020-08-04 |
Shortage status | Resolved |
Updated date | 2020-08-05 |
Company comments | On 125% Allocation Effective August 4, 2020 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-18 | English | Compare |
v2 | 2020-03-18 | French | Compare |
v3 | 2020-03-18 | English | Compare |
v4 | 2020-03-18 | French | Compare |
v5 | 2020-08-05 | English | Compare |
v6 | 2020-08-05 | French | Compare |
Showing 1 to 6 of 6